Altria Group, Inc.
MO · NYSE
- $68.35
- $109.49B
- Open
- —
- —
- $65.41 - $68.38
- $54.70 - $77.06
- —
- —
- 11.81M
About Altria Group, Inc.
Altria sells tobacco and nicotine products, centered on its smokable-products business, while expanding oral nicotine pouches and other smoke-free products. Smokable products remain the principal revenue and profit base, with pricing helping offset declining cigarette volumes; nicotine pouches and the broader smoke-free portfolio are the main growth areas. Its customers are adult nicotine consumers, including cigarette, oral-nicotine and other tobacco users. Altria reported $23.3 billion of FY2025 revenue and $6.9 billion of net income, versus $24.0 billion and $11.3 billion, respectively, in FY2024.
Notable Price Movement
- Aug 3-7$68.350.03%
Altria fell $6.75, or 9.02%, from $74.82 to $68.07 over the period. The stock was essentially flat through Tuesday, then dropped nearly 9.3% on July 30 on second-quarter results that missed earnings and revenue estimates, alongside lower cigarette shipments. Higher pricing supported smokeable-products revenue and profit, but investors focused on declining cigarette volumes, discount-brand share gains and the weaker earnings outlook. Trading volume more than doubled to 21.3 million shares on the selloff. Altria recovered modestly on July 31, then gave back those gains as the stock drifted from $68.26 to $68.07 on August 3-4. Management’s narrower 2026 earnings outlook and ongoing smoke-free transition outweighed commentary on nicotine-pouch growth and shareholder returns.
Stories & Analysis
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
